Rosuvastatin and Niacin: Can You Take Them Together?

High: Consult Your DoctorConflict
Learn about each ingredient:RosuvastatinNiacin

Quick answer

Niacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to rosuvastatin's risk of muscle injury, including rhabdomyolysis, a rare but severe breakdown of muscle that can harm the kidneys. The Crestor label reports cases of myopathy and rhabdomyolysis with lipid-modifying doses of niacin and asks prescribers to weigh the benefit against that risk and to monitor for muscle symptoms; it does not give a rate. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.

Do not add niacin at cholesterol-lowering amounts to rosuvastatin unless your prescriber has decided the benefit outweighs the muscle risk and is following you. Report new muscle pain, tenderness, weakness or dark urine promptly, and check any B3 or cholesterol supplement with your doctor or pharmacist.

What happens?

Rosuvastatin can injure muscle, and cholesterol-dose niacin adds to that risk of myopathy and rare rhabdomyolysis.

1

Added muscle risk

Rosuvastatin can cause myopathy on its own, and the Crestor label says niacin at 1 gram a day or more adds to that risk.

2

Muscle injury

Myopathy shows up as muscle pain, tenderness or weakness with a rise in the muscle enzyme CK.

3

Rare kidney danger

In rare cases muscle injury becomes rhabdomyolysis, which releases muscle proteins that can harm the kidneys.

The Crestor label warns about niacin at <strong>1 gram a day or more</strong>; with simvastatin, that kind of niacin raised definite myopathy about <strong>4-fold</strong>.

Why is this important?

This is an FDA label warning, and the size of the muscle risk was measured in one of the largest niacin trials ever run, with another statin.

Label-reported cases

The Crestor label reports cases of myopathy and rhabdomyolysis with lipid-modifying doses of niacin and asks prescribers to weigh the benefit.

Measured with another statin

With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold (0.16 versus 0.04 percent a year).

No heart benefit to offset it

In two large trials of people on a statin, adding niacin did not reduce heart attacks, strokes or other major vascular events.

Large trials did not show a heart benefit from adding niacin to a statin, which is why the label asks prescribers to weigh the benefit against the muscle risk.

What should you do?

The practical fix is simple: separate the doses.

Treat cholesterol-dose niacin as a prescriber decision

Best practical schedule

Before starting niacin
Ask your prescriber before adding any niacin product sold for cholesterol, and mention if you are of Asian descent, 65 or older, or have kidney or thyroid problems.
Every day on both
If your prescriber chose the combination, take both as prescribed and notice any new muscle symptoms, especially early on and after dose increases.
If symptoms appear
Call your doctor about unexplained muscle pain, tenderness, weakness or dark urine; your doctor may check your CK level.

Important reminders

  • •The warning is about niacin at 1 gram a day or more, not multivitamin amounts.
  • •Niacinamide is a different form of vitamin B3 and is not what the warning describes.
  • •Slow-release niacin still raised muscle problems in the large simvastatin trial.
  • •Never stop or change rosuvastatin on your own; talk to your doctor first.

Because adding niacin to a statin did not reduce heart attacks or strokes in large trials, your prescriber may suggest a different approach if your cholesterol needs more lowering.

Which specific products are affected?

Many common Niacin products can affect this interaction.

Rosuvastatin products this applies to

Crestor (rosuvastatin)Generic rosuvastatin tablets

Niacin products at cholesterol-lowering amounts

Niaspan and generic extended-release niacinImmediate-release niacin (nicotinic acid)High-strength over-the-counter niacin sold for cholesterolSlow-release or sustained-release niacin supplements

Other sources

  • •Standard multivitamins and B-complex products contain far less niacin than the 1 gram a day the warning describes.
  • •Niacinamide (nicotinamide) is a different form of vitamin B3 and is not used to lower cholesterol.

Read the Supplement Facts label for the form of vitamin B3 and the amount per serving, and ask your pharmacist if a product is sold for cholesterol.

The bottom line

Niacin at cholesterol-lowering amounts adds to rosuvastatin's risk of muscle injury, and in rare cases rhabdomyolysis. The Crestor label reports cases with lipid-modifying doses of niacin (1 gram a day or more) and asks prescribers to weigh the benefit and watch for muscle symptoms. With simvastatin, a large trial found adding niacin raised definite myopathy about 4-fold without lowering major vascular events.

Multivitamin amounts of niacin, and niacinamide, are not what this warning is about.

What happens when you take rosuvastatin with niacin?

Rosuvastatin (Crestor) is a statin that lowers LDL cholesterol. Niacin is vitamin B3. In large amounts, 1 gram a day or more, niacin is also used to change blood fats, either as a prescription (such as Niaspan) or as a high-strength supplement. Rosuvastatin can injure muscle, and niacin at those amounts adds to that risk.

  1. Rosuvastatin can cause myopathy: muscle pain, tenderness or weakness with a rise in the muscle enzyme creatine kinase (CK).
  2. The Crestor label lists niacin at lipid-modifying doses (1 gram a day or more) among the drugs that increase the risk of myopathy and rhabdomyolysis.
  3. In rare cases, muscle injury becomes rhabdomyolysis, where damaged muscle releases proteins that can harm the kidneys.
  4. The label reports that cases of myopathy and rhabdomyolysis have occurred with this combination. It does not say how often.
  5. The label also says Asian patients may be at higher risk of myopathy on rosuvastatin, and that higher rosuvastatin doses carry more risk.

Why is this important?

This is a label warning, not a theoretical concern. The Crestor label asks prescribers to consider whether the benefit of adding cholesterol-dose niacin outweighs the higher risk of muscle injury, and to watch for muscle symptoms if they go ahead.

The size of the risk has not been measured with rosuvastatin itself. It was measured with simvastatin, another statin: in the HPS2-THRIVE trial, adding extended-release niacin raised definite myopathy about 4-fold, and muscle problems were far more common in participants in China than in Europe.

The extra risk also comes without a proven heart benefit. In two large trials of people already on a statin (simvastatin), adding niacin did not reduce heart attacks, strokes or other major vascular events. That is why niacin is now rarely added to a statin, and why the decision belongs to your prescriber.

What should you do?

The principle is simple: cholesterol-dose niacin is a medicine decision, not a supplement add-on, when you take rosuvastatin.

Before starting niacin: If you take rosuvastatin and are thinking about a high-strength niacin product for cholesterol, talk to your prescriber first. Mention if you are of Asian descent, are 65 or older, or have kidney or thyroid problems, since the label lists these as reasons for higher muscle risk.

Every day while on both: If your prescriber has decided the combination is right for you, take both exactly as prescribed and pay attention to your muscles, especially in the first weeks and after a dose increase of either one.

If symptoms appear: Contact your doctor promptly about unexplained muscle pain, tenderness or weakness, especially with fever, tiredness or dark urine. Do not stop or change rosuvastatin on your own; your doctor may check your CK level and decide what to change.

Which specific products are affected?

On the medication side, this applies to Crestor and generic rosuvastatin tablets.

On the niacin side, the label warning is about niacin (nicotinic acid) at 1 gram a day or more. That includes prescription extended-release niacin (Niaspan and generics), immediate-release niacin, and high-strength over-the-counter niacin sold for cholesterol. The small amounts of niacin in a standard multivitamin or B-complex are far below that level. Niacinamide (nicotinamide), a different form of vitamin B3 found in many multivitamins and skin products, is not used to lower cholesterol and is not the form the label describes. Read the Supplement Facts label for the form and the amount per serving.

The science behind it

The Crestor prescribing information on DailyMed (section 7.1) states that cases of myopathy and rhabdomyolysis have occurred with lipid-modifying doses of niacin (1 gram a day or more) taken with rosuvastatin. It tells prescribers to weigh the benefit against that risk and, if they use the combination, to monitor for muscle symptoms, particularly when starting and when raising the dose of either drug.

The best measured rate comes from a different statin. In HPS2-THRIVE, 25,673 adults with vascular disease on simvastatin were randomized to extended-release niacin with laropiprant or placebo. Definite myopathy occurred in 75 people on niacin versus 17 on placebo (risk ratio 4.4), and any myopathy was much more common in China (HPS2-THRIVE Collaborative Group, Eur Heart J 2013, PMID 23444397). Major vascular events did not fall (13.2 versus 13.7 percent) (N Engl J Med 2014, PMID 25014686), and in AIM-HIGH, adding niacin to simvastatin gave no extra benefit over 3 years (N Engl J Med 2011, PMID 22085343).

Rosuvastatin and extended-release niacin have been tested together for blood fats in smaller, shorter trials. In 270 people over 24 weeks, rosuvastatin alone was better tolerated than the combinations (Capuzzi DM, et al. Am J Cardiol 2003, PMID 12767421), and a 12-week study of 292 people, in which one of four groups took rosuvastatin with extended-release niacin, reported no drug-related myopathy (McKenney JM, et al. Atherosclerosis 2007, PMID 17239888). Trials this size and length cannot measure a rare muscle injury. What was not shown: no trial has measured the myopathy rate of niacin with rosuvastatin specifically, and the warning does not cover multivitamin amounts.

Frequently Asked Questions

Is the niacin in my multivitamin a problem with rosuvastatin?

The label warning is about niacin at 1 gram a day or more. Multivitamins contain far less. If you are unsure about a product, show the label to your pharmacist.

Why would anyone take niacin with a statin?

Niacin raises HDL cholesterol and lowers triglycerides, so it was once added to statins. In large trials, adding it to a statin did not reduce heart attacks or strokes and raised side effects, so it is now used far less.

Does flush-free or slow-release niacin avoid the problem?

Slow-release niacin does not: the large trial that measured the muscle risk used an extended-release form. Products sold as flush-free were not tested. Ask your pharmacist what form of niacin a product contains and how much.

Why does being of Asian descent matter?

The Crestor label says Asian patients may be at higher risk of myopathy on rosuvastatin, and in the simvastatin trial, muscle problems with niacin were much more common in participants in China.

What muscle symptoms should I watch for?

Unexplained muscle pain, tenderness or weakness, especially with fever, feeling unwell or dark urine. Contact your doctor promptly rather than waiting.

Is niacinamide the same as niacin?

No. Niacinamide is another form of vitamin B3 that is not used to lower cholesterol and is not the form the label warning describes.

Key takeaways

  • Niacin at cholesterol-lowering amounts (1 gram a day or more) raises the risk of muscle injury with rosuvastatin, according to the Crestor label.
  • The label reports cases of myopathy and rhabdomyolysis and asks prescribers to weigh the benefit and monitor for muscle symptoms.
  • With simvastatin, adding extended-release niacin raised definite myopathy about 4-fold without reducing major vascular events.
  • Multivitamin amounts of niacin, and niacinamide, are not what the warning is about.
  • Report new muscle pain, weakness or dark urine promptly, and never change rosuvastatin on your own.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Lovastatin + Niacin

high

Niacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to lovastatin's risk of muscle injury (myopathy), including rare rhabdomyolysis, a severe breakdown of muscle that can harm the kidneys. The lovastatin label says to use caution with this combination because niacin can cause myopathy on its own, asks prescribers to weigh the benefit against the risk, and notes that in uncontrolled studies most patients who developed myopathy on lovastatin were also taking cyclosporine, gemfibrozil or niacin. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.

Atorvastatin + Niacin

high

Adding cholesterol-dose niacin to atorvastatin raises the risk of muscle injury (myopathy, rarely rhabdomyolysis) without improving cardiovascular outcomes in patients already well treated with a statin.

Rosuvastatin + Coq10

low

Rosuvastatin blocks HMG-CoA reductase, the enzyme that makes both cholesterol and coenzyme Q10, so it modestly lowers circulating CoQ10. A meta-analysis of placebo-controlled trials found the drop was similar for rosuvastatin and for fat-soluble statins. Mitochondrial impairment is only one proposed mechanism for statin-associated muscle symptoms. This is a possible-benefit pairing, not a dangerous one.

Rosuvastatin + Berberine

low

Rosuvastatin is carried into liver cells by the OATP1B1 transporter. In a laboratory study using human liver-cell cultures, berberine increased OATP1B1 activity and pushed more rosuvastatin into the cells. This is an early, test-tube signal only: there is no human or animal data showing it changes blood levels, cholesterol response, or side-effect risk in real life.

Gemfibrozil + Red Yeast Rice

high

Red yeast rice supplies monacolin K, a compound chemically identical to the statin lovastatin. Combining it with gemfibrozil, a fibrate, can add up to serious muscle injury. The fibrate is itself toxic to muscle and also raises circulating statin levels by interfering with how the statin is cleared, so the two effects stack toward myopathy and, in the worst case, rhabdomyolysis with kidney injury.

Niacin + Red Yeast Rice

moderate

Red yeast rice contains monacolin K, which is chemically identical to the statin lovastatin, so it behaves as a low-dose statin. Lipid-modifying amounts of niacin can independently injure skeletal muscle, and combining a lovastatin-class agent with such niacin can add to the risk of muscle pain or damage (including, rarely, rhabdomyolysis). Because red yeast rice acts as a variable-strength statin, the same additive muscle-toxicity concern applies when it is taken alongside high-dose niacin.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free